724 related articles for article (PubMed ID: 21041655)
21. Pharmacologic Induction of Endotoxin Tolerance in Dendritic Cells by L-Kynurenine.
Manni G; Mondanelli G; Scalisi G; Pallotta MT; Nardi D; Padiglioni E; Romani R; Talesa VN; Puccetti P; Fallarino F; Gargaro M
Front Immunol; 2020; 11():292. PubMed ID: 32226425
[TBL] [Abstract][Full Text] [Related]
22. Aryl hydrocarbon receptor signaling mediates expression of indoleamine 2,3-dioxygenase.
Vogel CF; Goth SR; Dong B; Pessah IN; Matsumura F
Biochem Biophys Res Commun; 2008 Oct; 375(3):331-5. PubMed ID: 18694728
[TBL] [Abstract][Full Text] [Related]
23. The indoleamine 2,3-dioxygenase pathway is essential for human plasmacytoid dendritic cell-induced adaptive T regulatory cell generation.
Chen W; Liang X; Peterson AJ; Munn DH; Blazar BR
J Immunol; 2008 Oct; 181(8):5396-404. PubMed ID: 18832696
[TBL] [Abstract][Full Text] [Related]
24. A tryptophan metabolite, kynurenine, promotes mast cell activation through aryl hydrocarbon receptor.
Kawasaki H; Chang HW; Tseng HC; Hsu SC; Yang SJ; Hung CH; Zhou Y; Huang SK
Allergy; 2014 Apr; 69(4):445-52. PubMed ID: 24397465
[TBL] [Abstract][Full Text] [Related]
25. Reimagining IDO Pathway Inhibition in Cancer Immunotherapy via Downstream Focus on the Tryptophan-Kynurenine-Aryl Hydrocarbon Axis.
Labadie BW; Bao R; Luke JJ
Clin Cancer Res; 2019 Mar; 25(5):1462-1471. PubMed ID: 30377198
[TBL] [Abstract][Full Text] [Related]
26. Kynurenine, a Tryptophan Metabolite That Increases with Age, Induces Muscle Atrophy and Lipid Peroxidation.
Kaiser H; Yu K; Pandya C; Mendhe B; Isales CM; McGee-Lawrence ME; Johnson M; Fulzele S; Hamrick MW
Oxid Med Cell Longev; 2019; 2019():9894238. PubMed ID: 31737181
[TBL] [Abstract][Full Text] [Related]
27. Norisoboldine, an isoquinoline alkaloid, acts as an aryl hydrocarbon receptor ligand to induce intestinal Treg cells and thereby attenuate arthritis.
Tong B; Yuan X; Dou Y; Wu X; Chou G; Wang Z; Xia Y; Dai Y
Int J Biochem Cell Biol; 2016 Jun; 75():63-73. PubMed ID: 27032495
[TBL] [Abstract][Full Text] [Related]
28. Tolerogenic Phenotype of IFN-γ-Induced IDO+ Dendritic Cells Is Maintained via an Autocrine IDO-Kynurenine/AhR-IDO Loop.
Li Q; Harden JL; Anderson CD; Egilmez NK
J Immunol; 2016 Aug; 197(3):962-70. PubMed ID: 27316681
[TBL] [Abstract][Full Text] [Related]
29. Curcumin Facilitates Aryl Hydrocarbon Receptor Activation to Ameliorate Inflammatory Astrogliosis.
Lin CH; Chou CC; Lee YH; Hung CC
Molecules; 2022 Apr; 27(8):. PubMed ID: 35458704
[TBL] [Abstract][Full Text] [Related]
30. Indoleamine 2, 3-Dioxygenase 1 Mediates Survival Signals in Chronic Lymphocytic Leukemia
Atene CG; Fiorcari S; Mesini N; Alboni S; Martinelli S; Maccaferri M; Leonardi G; Potenza L; Luppi M; Maffei R; Marasca R
Front Immunol; 2022; 13():832263. PubMed ID: 35371054
[TBL] [Abstract][Full Text] [Related]
31. Tryptophan depletion sensitizes the AHR pathway by increasing AHR expression and GCN2/LAT1-mediated kynurenine uptake, and potentiates induction of regulatory T lymphocytes.
Solvay M; Holfelder P; Klaessens S; Pilotte L; Stroobant V; Lamy J; Naulaerts S; Spillier Q; Frédérick R; De Plaen E; Sers C; Opitz CA; Van den Eynde BJ; Zhu J
J Immunother Cancer; 2023 Jun; 11(6):. PubMed ID: 37344101
[TBL] [Abstract][Full Text] [Related]
32. Interferon-γ induces a tryptophan-selective amino acid transporter in human colonic epithelial cells and mouse dendritic cells.
Bhutia YD; Babu E; Ganapathy V
Biochim Biophys Acta; 2015 Feb; 1848(2):453-62. PubMed ID: 25450809
[TBL] [Abstract][Full Text] [Related]
33. Targeting the IDO1/TDO2-KYN-AhR Pathway for Cancer Immunotherapy - Challenges and Opportunities.
Cheong JE; Sun L
Trends Pharmacol Sci; 2018 Mar; 39(3):307-325. PubMed ID: 29254698
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of acute lethal pulmonary inflammation by the IDO-AhR pathway.
Lee SM; Park HY; Suh YS; Yoon EH; Kim J; Jang WH; Lee WS; Park SG; Choi IW; Choi I; Kang SW; Yun H; Teshima T; Kwon B; Seo SK
Proc Natl Acad Sci U S A; 2017 Jul; 114(29):E5881-E5890. PubMed ID: 28673995
[TBL] [Abstract][Full Text] [Related]
35. Functional and phenotypic effects of AhR activation in inflammatory dendritic cells.
Bankoti J; Rase B; Simones T; Shepherd DM
Toxicol Appl Pharmacol; 2010 Jul; 246(1-2):18-28. PubMed ID: 20350561
[TBL] [Abstract][Full Text] [Related]
36. Bone marrow CD11b(+)F4/80(+) dendritic cells ameliorate collagen-induced arthritis through modulating the balance between Treg and Th17.
Zhang L; Fu J; Sheng K; Li Y; Song S; Li P; Song S; Wang Q; Chen J; Yu J; Wei W
Int Immunopharmacol; 2015 Mar; 25(1):96-105. PubMed ID: 25619457
[TBL] [Abstract][Full Text] [Related]
37. Consequences of AhR activation in steady-state dendritic cells.
Simones T; Shepherd DM
Toxicol Sci; 2011 Feb; 119(2):293-307. PubMed ID: 21097750
[TBL] [Abstract][Full Text] [Related]
38. Differential regulation of Th17 and T regulatory cell differentiation by aryl hydrocarbon receptor dependent xenobiotic response element dependent and independent pathways.
Mohinta S; Kannan AK; Gowda K; Amin SG; Perdew GH; August A
Toxicol Sci; 2015 Jun; 145(2):233-43. PubMed ID: 25716673
[TBL] [Abstract][Full Text] [Related]
39. Early Immune Regulatory Changes in a Primary Controlled Human Plasmodium vivax Infection: CD1c
Woodberry T; Loughland JR; Minigo G; Burel JG; Amante FH; Piera KA; McNeil Y; Yeo TW; Good MF; Doolan DL; Engwerda CR; McCarthy JS; Anstey NM
Infect Immun; 2017 Jun; 85(6):. PubMed ID: 28320838
[No Abstract] [Full Text] [Related]
40. Adrenomedullin, a neuropeptide with immunoregulatory properties induces semi-mature tolerogenic dendritic cells.
Rullé S; Ah Kioon MD; Asensio C; Mussard J; Ea HK; Boissier MC; Lioté F; Falgarone G
Immunology; 2012 Jun; 136(2):252-64. PubMed ID: 22348691
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
